🔎 Trials Near Me

Hjem › Type 2-diabetes › Iowa

Type 2-diabetes kliniske forsøg i Iowa

10 studier for Type 2-diabetes søger deltagere på steder i Iowa.

Byer i Iowa

Officiel studietekst (engelsk)

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Iowa Diabetes & Endo Res Ctr, West Des Moines
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 30. sep. 2026 · NCT07817251

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

  • MercyOne Iowa Heart Center, West Des Moines
RekruttererFrivillige med god helbredstilstand velkomne
Alder 55 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT06112418

Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)

  • Iowa Diabetes and Endocrinology Research Center, West Des Moines
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07296484

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • University of Iowa, Iowa City
RekruttererFase 3
Alder 10 til 18 · Alle køn · Opdateret 9. sep. 2026 · NCT07282613

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

  • Iowa Diabetes Research, West Des Moines
RekruttererFase 3
Alder 18 til 99 · Alle køn · Opdateret 3. sep. 2026 · NCT07684144

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

  • West Broadway Clinic, Council Bluffs
  • University of Iowa Prev Inter Ctr, Iowa City
  • Iowa Diab & Endo Res Center, West Des Moines
RekruttererFase 3
Alder 45 og opefter · Alle køn · Opdateret 1. sep. 2026 · NCT07797335

A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus

  • Research Site, Sioux City
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT07662109

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • University of Iowa Stead Family Children's Hospitals, Iowa City
RekruttererFase 3
Alder 10 til 17 · Alle køn · Opdateret 7. aug. 2026 · NCT06739122

IH, Brain Health, and T2D

  • University of Iowa, Iowa City
RekruttererFrivillige med god helbredstilstand velkomne
Alder 60 til 85 · Alle køn · Opdateret 13. mar. 2026 · NCT07173543

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.